A Phase I dose-finding and safety study of AZD8931 with Oxaliplatin and Capecitabine chemotherapy in patients with Oesophago-gastric adenocarcinoma: the randomised expansion phase... per Thomas, A, Virdee, P, Eatock, M, Lord, S, Falk, S, Anthoney, D, Turkington, R, Goff, M, Elhussein, L, Collins, L, Moschandreas, J, Middleton, M

Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma per Noble, F, Lloyd, MA, Turkington, R, Griffiths, E, O'Donovan, M, O'Neill, JR, Mercer, S, Parsons, SL, Fitzgerald, RC, Underwood, TJ, Occams Consortium